| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |